S. M. Discovery Group (SMDG)

S. M. Discovery Group (SMDG) is an award winning and pioneering biotechnology company with the mission of developing lifesaving therapeutics for some of the most debilitating diseases. SMDG has developed innovative, patent-protected, therapeutic platforms for targeted delivery of therapeutics including genetic medicines to the brain and other organs. SMDG is currently utilises these platforms and is developing therapeutics for neurodegenerative and rare paediatric diseases and immune disorders. SMDG has received numerous recognitions and awards including: • Prestigious neuroscience journal of Fluids and Barriers of CNS, notable research and technology paper, 2020 • UK Life Sciences Innovator 2023 (UK Most Innovative Lifesciences Companies), 2023 • North East UK, Most innovative Companies, 2023 • Finalist, Bionow, Project of the year, 2021 • SME Magazine, CEO of the Year 2024, Biotech CEO leading discovery and developing life-saving therapies • Dr Farhangrazi Profiled and Interviewed in the prestigious Nature Journal, 2023 • Dr Farhangrazi Profiled by Rosalind Franklin Institute, 2023 • Finalist in Pharma Industry Awards UK 2024 in the category of Research and Development Achievement Award: S. M. Discovery - Pioneering Therapeutic Platforms • Finalist in Pharma Industry Awards UK 2024 in the category of Women in Pharma Award: S. M. Discovery Group - Dr Shadi Farhangrazi